 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/349627
Assay Development and Technologies, 2nd Edition
|
Description: |
'Assay Development & Technologies, 2nd Edition' offers essential information to speed up and simplify assay development.
This professional development guide thoroughly evaluates the capabilities, strengths, weaknesses, and expectations of leading assays and assay technologies to provide you with the information necessary to select and develop the appropriate assay for the task at hand.
The purpose of this report is to help biotechnology and pharmaceutical professionals choose and develop appropriate assays. This Second Edition includes additional content to reflect recent advancements in assay technology. A presentation of the many applications for whole cell assays as well as an expanded discussion of assay multiplexing has been added. This material recognizes the growing importance of high content, cell-based assays in drug discovery and candidate development. The section on assay methods for ion channels has also been expanded due to the emergence of analytical platforms for high-throughput screening of this very significant pharmaceutical target class. Finally, a lengthy appendix devoted to fluorescent proteins has been added that discusses the assay applications and properties of these important “reporter” molecules.
Emphasis is on discovery and R&D stages, although these assays are also important for manufacturing and QC. This report will present information on both high-content and highthroughput assays. Because it is intended to facilitate the proper choice of assay formats, this report includes many detailed comparisons between the leading possibilities for assays.
This report also emphasizes certain, of the more common, assays in biopharma. These include specific discussions of measuring compound quantity, microbial contamination, binding, enzymes, G protein-coupled receptors (GPCRs), ion channels, toxicology-pharmacology, and genetic polymorphism. It also includes emphasis on cell-based assay formats, and the most modern assay platforms, featuring miniaturization and automation.
This report presents emerging technologies for assays from the point of view of capabilities, strengths and weaknesses, and expectations for the future. The vocabulary and style of this report assume that the reader has completed at least a bachelor level education in molecular biology, biochemistry, immunology, or a similar scientific field. Experience or familiarity with assay terminology and technologies are generally not assumed, but an understanding of the business context of the assay program is important for implementing the procedures described herein.
This report does contain some technical instructions; in order to be truly useful, many tips for troubleshooting comprise specific materials and methods, however, it is not a laboratory recipe book. Detailed laboratory procedures are mostly left to development by individual labs, in response to local assay goals, policies, and requirements. The information contained here is intended to provide knowledge of assays and assay development that normally accumulate over many years of personal experience with laboratoryassay technology. This information does not supersede requirements imposed by the assay laboratory’s corporate, legal, or regulatory environment. While it cannot replace the judgment of experienced laboratory scientists and team managers, it should greatly assist such persons in their duties. |
|
Contents: |
Chapter 1: Executive Summary Purpose and Scope Summary Additional Information
Chapter 2: Introduction. Definitions Assays and Analytes Qualitative and Quantitative Targets Stains, Dyes, Tags, Labels, and Reporters Potentially Confusing Terminology Polarization Quenching
Brief Historical Perspective Diagnostics Drug Discovery
Basic Issues Sampling Primary and Secondary Assays High- throughput Versus High-content Different Error Tolerance Confounding Analytes
Drug Development and Manufacturing Impurities Therapeutics
Miniaturization Microplates 96-well Plates Evaporation Non-reproducibility Arrays and Microarrays
Chapter 3: Common Assays Quantitation of Therapeutics and Other Compounds Weighing Extinction Coefficient. Evaporative Light Scattering Detection Nuclear Magnetic Resonance Chemiluminescent Nitrogen Detection
Microbial Contamination Culture Tests Culture Media Validation and Archiving PCR ELISA
Binding Molecular Size Surface Plasmon Resonance Biochemical Function Enzyme Reconstitution Labeling
Enzyme Assays. Proteases Site-specific Proteases HPLC Protease Assays Fluorescence Based Protease Assays Color Based Protease Assays Gain of Biological Function. Kinases and Phosphorylases Radiometric Phosphate Assays Non-radiometric Phosphate Assays Chelation-based Phosphate Assays Phosphate Immunoassays
G protein-coupled receptors Cell Culture Expression Promiscuous GPCR cAMP Calcium and IP3
Ion Channels Ion Flux Radiometry Atomic Absorption Spectroscopy Patch-clamp Reporter Dyes Voltage Sensitive Dye Systems Membrane Binding Assays
Toxicology and Pharmacology Ion Channel Assays in Cardiac Toxicity Gene Expression in ADME Hepatotoxicity
Genetic Polymorphism Restriction Fragment Length Polymorphisms Hybridization Assays PCR for SNP Single Base Extension
Chapter 4: General Assay Design Universal Considerations Precision Laboratory Technique Reagent Purity Storage Blocking. Water Quality Cell and Tissue Quality Room Temperature Time Washing Other Sources of Non-reproducibility Repeatability between Labs Optimal Reagent Amounts Serial Dilutions Standard Curves Linearity Range Mathematical Modeling Limits Interpolation Data Analysis Multiplicity Signal-to-background and Signal-to-noise Ratios Z-prime
Nature of Analyte and Matrix Analyte Stability Microbial Contamination Metabolic Processes Intractable Stability Problems Blocking Inadvertent Adsorption Separation and Enrichment Separation Enrichment Prederivitization Internal Standard “Spike”
Assay Objectives Research, Development, or Process Budget Throughput Mixtures and Single Compound Screening. Scalability Sensitivity Error Tolerance False Positives and False Negatives
Chapter 5: Format Homogeneous and Heterogeneous Pros and Cons Heterogeneous Immobilization
Direct and Indirect Second Mediators Second Antibodies Biotin-avidin Enzyme Reporter Systems Alkaline Phosphatase and Horseradish Peroxidas Substrates
Agonists and Antagonists Competition
In vitro and in vivo In Vitro Assays In Vivo Assays Whole Organisms Biological Material Isolated Tissues and Perfused Organs Cell Cultures Bacteria and Eukaryotes Cell Lines and Primary Cultures Adherent and Suspension Cultures In Vitro Assays Blood and Blood Fractions Sub-cellular Fractions RER and Liver Microsomes
Chapter 6: Readout (Reporting Format) Colorimetric and Fluorometric Colorimetric Assays Simple Ultraviolet and Visible Light Absorption Chromatography Staining Chromogenic Substrates Fluorometric Assays Fluorogenic Enzyme Cleavage Substrates Fluorescence Quenching EDANS and Dabcyl Green Fluorescent Protein Factors That Can Perturb GFP Fluorescence pH Effects and GFP Dimerization Denaturation Organic Solvents and GFP Proteases and GFP Detergents and GFP Oxidizing and Reducing Agents and GFP Chaotropes Physical Characteristics of GFP Fluorescence Fluorescence Measurements Excitation Emission Molecular Extinction Coefficients Quantum Yield Stokes Shift Fluorescence Lifetime Energy Transfer Radiative (Trivial) Energy Transfer Radiationless Energy Transfer Common Problems in GFP Fluorescence Detection Autofluorescence Recognizing Autofluorescence Reducing Autofluorescence Photostability Photobleaching Photoisomerization Photoconversion Fluorescence Detection and GFP General Considerations Available Light Sources for GFP Excitation GFP Emission Spectra and Fluorescence Detection Systems The Role of Filter Selection Instrument Sensitivity Spectrophotometry Fluorimetry Fluorometric Plate Readers Flow Cytometry Native PAGE Electrophoresis Fluorescence Microscopy and Imaging Environment Sample Preparation and Maintenance Fluorescence Microscope Set-Up Types of Fluorescence Microscopy Wide-field Fluorescence Microscopy Confocal Microscopy Two Photon Excitation Microscopy (TPEM) Advanced Fluorescence Microscopy Techniques Fluorescence Recovery After Photobleaching (FRAP) Fluorescence Loss in Photobleaching (FLIP) Fluorescence Correlation Microscopy (FCM) Fluorescence Lifetime Imaging (FLIM) Fluorescence Resonance Energy Transfer (FRET) Microscopy Total Internal Reflection Fluorescence Microscopy (TIR-FM)
Calibrations and Data Analysis Data Output from Spectrophotometers A280 Readings Wavelength Scans. Molar Extinction Coefficients (MEC’s) Data Output from Fluorimeters Data Output from Fluorometric Plate Readers Data Output from Flow Cytometry Data Output from Native PAGE Electrophoresis Data Output from Microscopy and Imaging Cameras Image Capture Image Analysis Image Storage Time-resolved Fluorometry LANCE DELFIA Fluorescence Polarization Chemiluminescence Electrochemiluminescence ALPHAScreen Aequorin
Radiometric Radiolabeling Radioimmunoassay Scintillation Proximity Assay
Biological Growth Special Growth Media
Other Readouts Chapter 7: Validation Installation and Operation Qualification Instruments and Equipment Manufacturer’s Certification and Specifications Establish Log Books. Assay Optimization General Factorial Design Consider the Worst Case Range Sensitivity Upper and Lower Limit of Quantitation (ULOQ and LLOQ) Linearity Precision and Accuracy Other Variables Physical Plant Personnel
Performance Qualification Instruments and Consumables Maintain Log Books Consumables Operation Re-certification Assay Parameters Data Certification
Scale-up General Step-by-step Process
Chapter 8: In Vitro Assays General Spectroscopy UV/vis Mass Spectroscopy. NMR Protein Assays Colorimetric Protein Assays Light Absorbance Dye Binding Metal Reduction Amino Acid Analysis. Protein Hydrolysis AAA via HPLC
Enzyme Assays Enzyme Stability Proteases Matrix Metalloproteases Blood Clotting Enzymes Kinases and Phosphorylases Kinases Radiolabel Incorporation Phosphate Analogs Measurement of Kinase under Constant ATP Concentration Coupling Kinase to NAD/NADH Ratio Phosphorylases Enzyme SPA EMIT
Binding Specificity Valence and Avidity Blocking and Washing8 Blocking Washing
Antibodies and Immunoassays Antibodies Structures and Fragments Classes Storage and Stability Polyclonal and Monoclonal Ab Monospecific Ab8 Immunoassays8 Radioimmunoassays Competitive RIA8 Antigen Capture RIA8 Fluorescence Immunoassays ELISAs Antigen-capture, Indirect Format Antigen Capture, Direct Format Sandwich Double Sandwich Western Sample System Membrane Antibodies Detection. “Classical” Immunoassays Agglutination Agar Assays Fluorescence Quenching Fluorescence Polarization Scintillation Proximity Assay SPA on Beads Other Binding Assays
Nucleic Acids General Sample Processing Polymerase Chain Reaction General Practical Considerations and Troubleshooting Quantitative PCR Reverse Transcriptase PCR (RTPCR) Hybridization Blots
Chapter 9: Cell-based Assay Application Areas and Associated Assays Available General Pitfalls. Cell Number and Viability Cell Line Stability Controls Autofluorescence Non-specific Binding Probe Specificity Reagent Stability and Variability Dead Cell Fraction
Fixed Cells Fixing Fluorescence In Situ Hybridization Immunofluorescence Assay Staining and Counter-staining
Whole Cells Cell ELISAs and ELISpots Cell ELISAs ELISpots Cytotoxicity RBC Lysis Chromium Release Hepatotoxicity Toxicity P450 Induction Surface Binding and Membrane Transport Surface Binding Membrane Transport Trafficking and Translocation MAPK NF-6B GPCR ?-arrestin Pitfalls Nuclear Receptors Cell Quantitation Cell Quantitation via DNA Staining Hoechst Stain Vitality Membrane Permeability Vital Stains Cell Leakage Division Growth Mitotic Markers Motility Apoptosis General Chromatin Degradation Example of Multivariate Analysis of Apoptosis and Necrosis Mitochondrial Membrane Potential Cytoskeletal Changes Cytoplasmic Enzymes Cell Surface Markers Annexin Cellular Morphology SPA in Microplates. Fluorescence
Flow Cytometry General Advantages and Limitations Advantages Limitations Fluorophore Selection Fluorescein Rhodamines Phycobiliproteins Cy Dyes Tandem Conjugates Controls Non-specific Binding Dead Cells Gating Applications Quantitative Microbiology Immunophenotyping
Lysates Gene Expression Microarrays Chips Protein Expression (Gene Induction)
Microscopy Stains Labels FISH and IFA
Chapter 10: Automation Platforms Miniaturization Pros and Cons Scaling
Robotics Conveyors and Workstations Integrated and Modular Examples Beckman Coulter CyBio Tecan Tomtec
Liquid Handlers General Applications Replication Dry Spotting Delivery Size Syringes Ink Jets and Pens Calibration Cross-contamination Sources Estimation and Intervention Pipet Tips Positive Displacement Liquid Sensing Tips
Cell Handling Culture Sample Prep
Microplate Equipment Microplates Polymer Materials Surface Treatments, Coatings, and Grafts Seals and Stickers Plate Handlers Washers. Bar Codes 1 Cleaning and Maintenance
Chapter 11: Emerging Technologies Image Analysis General Issues Practical Considerations Assay Format and Probe. Data Format Dynamic Range Depth of Field Cell Counting Illumination Filters and Dichroic Mirrors CCD Camera Multiplexing Multiplexed Assay Technologies The Need for Multiplexing Key Competitive Advantages of Multiplexed Assay Technologies Over Micro-Arrays Automation An Example
Higher Density Formats Multiplexing in 96-well Plates 384-well Plates High Density Microplates Microarrays and Chips Commercial Microarrays Protein Microarrays Homemade Microarrays Microfluidics
New Technologies Planar Waveguide Technology Flow Cytometry with Labeled Beads and Libraries Branched DNA Binding Assay Single Molecule Detection Virtual Screening
Chapter 12: Information Management Data Analysis. Acquisition Signal-to-background and Signal-to-noise Ratios Precision and Accuracy Type 1 and Type 2 Error Random and Systematic Error Binning and Pooling
Statistics Binding Constants Error and Standard Error Correlation Coefficient Standard Deviation Coefficient of Variance Z’ factor More Complicated Statistics Error Detection Error Correction Normalization and Data Condensing Data Standardization Statistical Analysis
Chapter 13: Appendices
Appendix 1: Resources for Detailed Protocols Organizations. Other Non-commercial Sites Journals and Other Commercial Publications
Appendix 2: Checklist for General Assay Development Research Guide for General Assay Development General Sample Data Standard Checklist To Be Used for Any Assay Development
Appendix 3: Microarray Assay Checklist Experiment Design Samples used, extract preparation and labeling Hybridization procedures and parameters Measurement data and specifications Array Design
Appendix 4: Vendors
Appendix 5: Examples of Troubleshooting In Vitro Early Development Sample Matrix pH Autofluorescence Problems with Miniaturization Liquid Handler Contamination Intermittent Robot Failure Late Stage Solubility Problem Cell-based Early Development Sample Matrix Toxicity Transient Expression Problems with Scale-up. Culture Contamination
Chapter 14: References
Table of Exhibits Exhibit 2.1 Common Causes of Non-reproducibility in Microplates Exhibit 3.1 General Assay Formats for Binding of Labeled Ligand. Exhibit 3.2 Common FRET Donor-quencher Pairs and their Minimum Förster .Radius (R0) Exhibit 3.2 Summary of Mainstream Technologies for Ion Channel Interrogation Exhibit 4.1 Major Assay Design Considerations and Potential Problems Addressed Exhibit 4.2 Common Causes of Assay Non-reproducibility Exhibit 4.3 Sample Standard Curve with Data Interpolation, Extrapolation Exhibit 4.4 Different Assay Emphasis at Various Drug Development Stages Exhibit 5.1 Comparison of Heterogeneous and Homogeneous Assay Formats Exhibit 5.2 Comparison of Adsorption and Covalent Coupling in Heterogeneous Assays Exhibit 5.3 Comparison of In Vitro and In Vivo Assays Exhibit 5.4 List of Common In Vivo Whole Animal Assays Exhibit 5.5 Comparison of Cell-based Assays and In Vitro Assays Exhibit 5.6 Common Cell Lines Used for Assays. Exhibit 5.7 Common Primary Cultures for Assay Exhibit 5.8 Common Coatings for Cell Culture Based Assays Exhibit 6.1 Advantages and Disadvantages of Fluorescent Formats for HTS Exhibit 6.2 General Factors Known to Perturb GFP Fluorescence Exhibit 6.3 Conditions Tolerated by Aequorea GFP (wt) Exhibit 6.4 Common Sources of Autofluorescence Exhibit 6.5 Comparative Analysis of Photobleaching in Select GFP Variants Exhibit 6.6 Examples of Light Sources for Fluorescence Excitation Exhibit 6.7 Examples of Laser Lines Used in the Excitation of Fluorescent Proteins Exhibit 6.8 Excitation Spectrum and Laser Lines Exhibit 6.9 Parameters to Consider when Choosing a CCD Camera Exhibit 6.10 Instrument Detection Limits for Fluorescein Exhibit 6.11 Advantages of Fluorimetry Exhibit 6.12 Factors to Consider when Making Fluorimetric Measurements Exhibit 6.13 Tips for Fluorescence Microplate Assays Exhibit 6.14 Some Variables Among Fluorescence Microplate Readers Exhibit 6.15 Sample Thickness and Microscopy Applications Exhibit 6.16 Advantages of Two-Photon Microscopy over Confocal Microscopy Exhibit 6.17 Requirements for Measurement of GFP Molar Extinction Coefficients Exhibit 6.18 Molar Extinction Coefficients for Selected GFP Variants Exhibit 6.19 Some Considerations when Measuring GFP Quantum Yields Exhibit 6.20 Confocal Imaging Software Features Exhibit 6.21 Typical DELFIA Assay Steps Exhibit 7.1 Example of Factorial Design Exhibit 7.2 Common Problems Arising from Automation of an Assay Exhibit 8.1 Comparison of Protein Assays Based on Light Absorbance. Exhibit 8.2 Comparison of Dye Binding Protein Assays. Exhibit 8.3 Comparison of Metal Reduction Protein Assays Exhibit 8.4 Binding Curves Plotted as Hyperbola and as Sigmoid. Exhibit 8.5 Useful Blocker Solutions Exhibit 8.6 Comparison of Different ELISA Formats Exhibit 8.7 Antigen Capture ELISAs Diagrammed, Direct and Indirect Formats. Exhibit 8.8 Sandwich ELISA and Competitive RIA Diagrammed Exhibit 8.9 Recommended Number of PCR Cycles by Template Amount Exhibit 8.10 PCR Primer Selection Criteria Exhibit 9.1 Cell-based Assay Application Areas and Associated Assays Available Exhibit 9.2 Common Pitfalls in Cell-based Assays Exhibit 9.3 Minimal Controls Required for Cell-based Assays. Exhibit 9.4 Troubleshooting FISH and IFA Exhibit 9.5 Measurable Biological Endpoints for Whole Cell Assays Exhibit 9.6 Sample ELISpot Protocol Exhibit 9.7 Suitable P450 Substrates Exhibit 9.8 Classical Inducers for Rat and Human Plated Hepatocytes Exhibit 9.9 Assayable Parameters for Vitality Exhibit 9.10 Assayable Markers for Apoptosis Exhibit 9.11 Common Applications for Flow Cytometry Assay Exhibit 9.12 Dye Selection for Flow Cytometry Exhibit 9.13 Controls Required for Flow Cytometry Exhibit 11.1 Assays Suitable for Development Using HCS Exhibit 11.2 Multiplexed Assay Concept Exhibit 11.3 Comparison of Different Multiplexed Assay Technologies Exhibit 12.1 Examples of Kinetic Constants for Fast Enzymes Exhibit 12.2 Ordered Steps for Quality Control of UHT Data |
|
Summary: |
Assays are procedures for detection or quantitation of a specific material within a sample that may contain other interfering materials. In biopharma, the measured material, also called analyte, is usually a drug or drug lead compound, a protein, a gene or gene product, or a particular impurity or metabolite. Some assays, called multivariate or multiplex, simultaneously report on the presence of more than one material. When it is necessary to treat the sample matrix to facilitate analysis, concentrating the analyte and removing interfering materials, care must be taken to determine the recovery efficiency of the pre-treatment, such as by including an internal standard.
While it is theoretically possible to develop an assay with both high sample throughput and high information content, usually one of these is optimized at the expense of the other. Highthroughput assays are commonly performed as an early screen, before investing in a more definitive high-content procedure. The former primary assays are generally faster and less expensive, and are often more prone to inaccuracies, compared to the latter secondary assays. There are many other illustrative ways to divide assays into two or more types. One is the division between in vitro and in vivo assays. Both are useful for biopharma assays. In drug discovery, in vitro procedures exhibit properties superior for primary assays, and in vivo assays often make better secondary screens. Cell-based assays fill an important gap between purely in vitro and in vivo assays, and offer intermediate levels of cost, throughput, and information. When faced with a choice between either in vitro or in vivo assay formats, consider the goals of the assay program. Generate the required data in the most efficient way possible.
Another division of assay technologies is between homogeneous and heterogeneous assays. Heterogeneous assays include a step for immobilization of the analyte, a reporter, or both. This capture step increases sensitivity by driving biochemical equilibria toward completion. But, like many means of signal amplification, it can also increase background. Homogeneous assays are performed without practical separation of the analyte from all other assay reagents. In addition to lower background, they usually offer higher throughput, compared to heterogeneous assays. Assays may be performed at standard scale, or at various levels of miniaturization. Miniaturization, using microplate and array formats, provides savings in some reagents and sometimes offers increased throughput. Expressed the other way, increased throughput generally requires some factor of miniaturization.
Sometimes assays directly measure the analyte according to its inherent properties. This includes the spectral properties of chemical compounds, and the ability of organisms to grow in a particular defined medium. More often an assay employs a series or cascade of targets and secondary materials that interact with the analyte and provide a robust signal. Common forms of signaling readout include radioactivity, color, fluorescence and other light-generating processes.
There are some aspects of assay development that are universally important for success. These include precision, optimization, standards, and data analysis. Other critical factors, such as scale, throughput, and accuracy often depend on requirements imposed by the four main aspects listed above. Proper validation of an assay, especially in GMP environments, requires appropriate development, with attention to all of these factors. When high-throughout is required, it is usually best to develop an assay at low-throughput and then migrate to an appropriate high-throughout platform. Simultaneously, the assay instrumentation may be tested with water or recycled consumables. Because of the resource drain created by testing a large set of samples for full qualification of such a system, high-throughout platforms are often only partly validated before beginning screening, with complete validation occurring as part of the ongoing assay operation.
Different analytes pose characteristic problems in assay development. For enzymes, the main problem is usually the efficiency and stability of the analyte under assay conditions, which must be carefully optimized. For binding measurements, the problem is background or non-specific binding, which is usually addressed via blocking. Antibodies (Ab) are convenient receptors used in many assays, especially immunoassays. Their limitations arise from the many different subtypes and varieties of Ab. DNA is a robust analyte, but the most sensitive assays for nucleic acids exhibit poor accuracy. |
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/349627
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 02/12/2008 03:59:23 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Assay Development and Technologies, 2nd Edition
|
|
Web Address: |
http://www.researchandmarkets.com/reports/349627
|
|
Office Code: |
|
OCIFGLJKRRZ
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Single User
|
|
€958.00
|
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353 1 481 1716 or +353 1 653 1571 - From Rest of World
 |
Page 2 of 2 Printed 02/12/2008 03:59:23
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder Name: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353 1 481 1716 or +353 1 653 1571 - From Rest of World
|
 |
 |
|
|